2,6-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 250mg

N-(2-Hydroxyethyl)maleimide>98.0%(HPLC)(N)1g

Ethyl 4-piperidone-N-carboxylate, 98.0%, 100g

1-(4-Chlorophenyl)imidazoline-2-thione, 98.0%, 1g

((4S,5S)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(di(naphthalen-1-yl)methanol), 95% 99%ee, 25g

(S)-4-Benzyl-5-oxo-morpholine-3-carboxylic acid, 95.0%, 250mg

3,4-Dichloropyridin-2-amine, 95.0%, 1g

Coomassie Brilliant Blue G-250 [for Electrophoresis]5g

4-(Trifluoromethyl)benzonitrile, 99.0%, 25g

4-(p-Tolyl)cyclohexanone>98.0%(GC)1g

3-Amino-5-methylpyridin-2(1H)-one, 95.0%, 1g

2-Chloro-8-methoxyquinoxaline, 95.0%, 5g

N-BENZYL-2,3-DIBROMOMALEIMIDE, 95.0%, 5g